This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ube Industries, Inc., Ube Corporation. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Hayato Nishiyama: Innovator in Pharmaceutical Compounds
Introduction
Hayato Nishiyama is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 3 patents to his name, Nishiyama continues to push the boundaries of innovation in his industry.
Latest Patents
Nishiyama's latest patents focus on substituted dihydropyrrolopyrazole compounds. The first patent outlines methods for producing a compound represented by a specific formula, which includes various structural components such as optionally substituted Calkylene groups and hydrogen atoms. The second patent provides a similar compound representation, emphasizing the pharmacological acceptability of the salts derived from these compounds.
Career Highlights
Hayato Nishiyama is currently employed at Ube Industries, Inc., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the company's portfolio of innovative products.
Collaborations
Nishiyama collaborates with talented colleagues, including Noriaki Iwase and Shigeyuki Kono. Together, they contribute to the innovative environment at Ube Industries, fostering creativity and scientific advancement.
Conclusion
Hayato Nishiyama exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaboration with colleagues highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile